Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
Journal Article
·
· Powder Diffraction
- Illinois Institute of Technology, Chicago, IL (United States); North Central College, Naperville, IL (United States)
- ICDD, Newtown Square, PA (United States)
The crystal structure of besifloxacin hydrochloride has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Besifloxacin hydrochloride crystallizes in space group P1 (#1) with a = 5.36596(8), b = 10.3234(4), c = 17.9673(14) Å, α = 98.122(5), β = 92.9395(9), γ = 96.1135(3)°, V = 977.483(13) Å3, and Z = 2. The crystal structure is approximately centrosymmetric. Strong N–H∙∙∙Cl hydrogen bonds form a corrugated ladder-like chain along the a-axis. The carboxylic acid group in each independent cation acts as the donor in a strong intramolecular O–H∙∙∙O hydrogen bond to an adjacent carbonyl group. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File™ (PDF®).
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 2423335
- Journal Information:
- Powder Diffraction, Journal Name: Powder Diffraction Journal Issue: 1 Vol. 38; ISSN 0885-7156
- Publisher:
- Cambridge University PressCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Crystal structure of ractopamine hydrochloride, C18H24NO3Cl
Crystal structure of butenafine hydrochloride, C23H28NCl
Powder X-ray diffraction of nintedanib esylate hemihydrate, (C31H33N5O4)(C 2H5O3S)(H2O)0.5
Journal Article
·
Wed Feb 28 19:00:00 EST 2024
· Powder Diffraction
·
OSTI ID:2581380
Crystal structure of butenafine hydrochloride, C23H28NCl
Journal Article
·
Wed Apr 19 20:00:00 EDT 2023
· Powder Diffraction
·
OSTI ID:2423336
Powder X-ray diffraction of nintedanib esylate hemihydrate, (C31H33N5O4)(C 2H5O3S)(H2O)0.5
Journal Article
·
Thu May 02 20:00:00 EDT 2024
· Powder Diffraction
·
OSTI ID:2581383